2025-03-12 – Press Releases – www.prnewswire.com
RAICHUR, India , March 12, 2025 /PRNewswire/ — Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug (IND) – Nor Ursodeoxycholic Acid (Nor…